Multiple sclerosis has imitator afflictions, and a diagnosis of MS or ALS is not the final word. If you know of someone with MS or ALS, please recommend to them, strongly, that they get an MRI of the ...
SALT LAKE CITY, April 25, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage ...
Amyotrophic lateral sclerosis develops through multiple pathways, so drug research in this neuromuscular disorder has pursued multiple targets. One of those targets faces some doubts after an ALS drug ...
People suffering from incurable neurological diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) hope new therapies and drugs will arrive sooner than later. A chronic and ...
The goal of this phase 1/2 open-safety clinical trial, which included 15 patients with multiple sclerosis (MS) and 19 patients with amyotrophic lateral sclerosis (ALS), was to assess the feasibility, ...
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive neurodegenerative disease. It affects your nerves and muscle tissue and worsens over time, eventually becoming fatal.
Rob Etherington drives an electric car with a personalized license plate that reads “CLENE,” as in Clene Nanomedicine, the company he leads as President and CEO: “Many people ask me, is it because ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback